PATENT CLAIM ANALYSIS

Application Number: 16191774
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "044000"]

Abstract:
The present invention provides methods of treatment using inhibitors of DEK protein and DEK activity. Such methods include, but are not limited to, methods of preventing, treating, and/or ameliorating inflammatory diseases, infections, autoimmune diseases, malignant diseases, and other diseases or conditions in which DEK has been implicated. Such inhibitors of DEK protein include, but are not limited to, pharmaceutical compositions including single stranded DNA or RNA aptamers capable of binding to DEK. In some embodiments, such aptamers are useful for diagnosing DEK related diseases or conditions. Related kits and compositions are further provided.

Claim (Index 7):
The method of  claim 1 , wherein said high affinity aptamer specific for said DEK target molecule comprises one or more modified nucleotides.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 98.0
- Lexical Diversity: 1.78689
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15557757', '14206814', '15545755', '15895723', '15023182']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7849135314001181
- 35 USC 102 Novelty (BERT): 0.5929001132755666
- Combined Prediction Score: 0.765712189587663
- Mean Citation Score: 333.701506
- Max Citation Score: 594.14734
- Similarity Product: 426.1474987419152

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test